

Systemic sclerosis is a rare autoimmune connective tissue disease that is associated with vascular and fibrotic complications that can cause concerns during pregnancy.1 Data from the UK show that from 2000 to 2022 the prevalence of systemic sclerosis in pregnant women had an average annual percantage increase of 1·7%,2 probably due to improved diagnosis and management. However, this increase also highlights the need to develop a better understanding of the effect of systemic sclerosis in pregnancy.
Rheumatology
|11th Mar, 2026
|The New England Journal of Medicine
Rheumatology
|11th Mar, 2026
|The New England Journal of Medicine
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet
Rheumatology
|11th Mar, 2026
|The Lancet